Skip to main content
SpringerLink
Log in

Value of carcinoembryonic antigen in the management of colorectal cancer

  • Current Status
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: The practical value of carcinoembryonic antigen (CEA) assay in the management of colorectal cancer after surgery is controversial. The value of CEA in the management of colorectal cancer was reviewed and discussed to justify the use of CEA assay in the management of colorectal cancer. METHODS: A retrospective study was performed on 318 patients who underwent resection by one surgeon (JYW) between 1981 and 1986 and who were followed for a minimum of 5 years or until death. RESULTS: The incidence of preoperative CEA levels >5 ng/ml in Dukes Stages A, B, C, and D were 0, 32, 48, and 79 percent, respectively. Five-year survival rates for groups with CEA levels ≤5 ng/ml and >5 ng/ml were 85 percent and 55 percent (P < 0.05), respectively, in Dukes Stage B patients and 64 percent and 37 percent (P < 0.05) in Stage C patients. The sensitivity and specificity of postoperative CEA monitoring in detecting recurrent diseases were 66 percent and 94 percent, respectively, for patients with a preoperative CEA value ≤5 ng/ml and 97 percent and 88 percent for patients with a higher preoperative CEA value. CONCLUSION: CEA is still the best tumor marker available to be used as an independent prognostic factor and as a monitor for recurrence of disease after primary tumor resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439–62.

    PubMed  Google Scholar 

  2. National Institutes of Health Consensus Development Conference. Carcinoembryonic antigen: its role as a marker in the management of cancer. Cancer Res 1981;41:2017–8.

    Google Scholar 

  3. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104:66–73.

    PubMed  Google Scholar 

  4. Wanebo HJ, Rao B, Pinsky CM,et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978;299:448–51.

    PubMed  Google Scholar 

  5. Staab HJ, Anderer FA, Brummendorf T, Stumpf E, Fischer R. Prognostic value of preoperative serum CEA level compared to clinical staging. Br J Cancer 1981;44:652–62.

    PubMed  Google Scholar 

  6. Wolmark N, Fisher B, Wieand HS,et al. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer—results from NSABP clinical trials. Ann Surg 1984;199: 375–81.

    PubMed  Google Scholar 

  7. Lewi H, Blumgart LH, Carter DC,et al. Preoperative carcinoembryonic antigen and survival in patients with colorectal cancer. Br J Surg 1984;71:206–8.

    PubMed  Google Scholar 

  8. Moertel CG, O'Fallon JR, Go VL, O'Connell MJ, Thynne GS. The preoperative carcinoembryonic antigen test in the diagnosis, staging and prognosis of colorectal cancer. Cancer 1986;58:603–10.

    PubMed  Google Scholar 

  9. LoGerfo P, Herter FP. Carcinoembryonic antigen and prognosis in patients with colon cancer. Ann Surg 1975;181:81–4.

    PubMed  Google Scholar 

  10. Goslin R, O'Brien MJ, Steele G,et al. Correlation of plasma CEA and CEA attaining in poorly differentiated colorectal cancer. Am J Med 1981;71:246–53.

    PubMed  Google Scholar 

  11. Chu DZ, Erickson CA, Russell MP,et al. Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Arch Surg 1991;126:3:314–6.

    PubMed  Google Scholar 

  12. Goslin R, Steele G Jr, MacIntyre J,et al. The use of preoperative plasma CEA levels for stratification of patients after curative resection of colorectal cancers. Ann Surg 1980;192:747–51.

    PubMed  Google Scholar 

  13. Steele G Jr, Ellenberg S, Ramming K,et al. (Gastrointestinal Tumor Study Group). Carcinoembryonic antigen monitoring among patients in multiinstitutional adjuvant G.I. therapy protocols. Ann Surg 1982;196:162–9.

    PubMed  Google Scholar 

  14. Scott NA, Wieand HS, Moertel CG,et al. Colorectal cancer: Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 1987;122:1375–9.

    Google Scholar 

  15. Arnaud JP, Koehl C, Adloff M. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. Dis Colon Rectum 1980;23:141–4.

    PubMed  Google Scholar 

  16. Mach JP, Vienny H, Jaeger P,et al. Long-term follow-up of colorectal carcinoma patients by repeated CEA radioimmunoassay. Cancer 1978;42:1439–47.

    PubMed  Google Scholar 

  17. Hine KR, Dykes PW. Serum CEA testing in the post-operative surveillance of colorectal carcinoma. Br J Cancer 1984;49:689–93.

    PubMed  Google Scholar 

  18. Staab HJ, Anderer FA, Stumpf E, Fischer R. Carcinoembryonic antigen follow-up and selection of patients for second-look operation in management of gastrointestinal carcinoma. J Surg Oncol 1978;10:273–82.

    PubMed  Google Scholar 

  19. Wood CB, Ratcliffe JG, Burt RW, Malcolm AJ, Blumgart LH. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg 1980;67:46–8.

    PubMed  Google Scholar 

  20. Staab HJ, Anderer FA, Stumpf E, Fischer R. Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am J Surg 1978;136:322–7.

    PubMed  Google Scholar 

  21. Boey J, Cheung HC, Lai CK, Wong J. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma. World J Surg 1984;8:279–86.

    PubMed  Google Scholar 

  22. Tate H. Plasma CEA in the post-surgical monitoring of colorectal carcinoma. Br J Cancer 1982;46: 323–30.

    PubMed  Google Scholar 

  23. Minton JP, Hoehn JL, Gerber DM,et al. Results of a 400 patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985;55:1284–90.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Colorectal Section, Chang Gung Memorial Hospital, Chang Gung Medical College, Taipei, Taiwan

    Jeng Yi Wang M.D., Reiping Tang M.D. & Jy Ming Chiang M.D.

Authors
  1. Jeng Yi Wang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reiping Tang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jy Ming Chiang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Wang, J.Y., Tang, R. & Chiang, J.M. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 37, 272–277 (1994). https://doi.org/10.1007/BF02048166

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02048166

Key words

Search

Navigation